Paradigm Biopharmaceuticals | PAR - Ebitda

Stock Price
0.30
Daily Change
-0.02 -4.76%
Monthly
-18.92%
Yearly
-44.95%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-5.86M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13.97M 332K Sep/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Telix Pharmaceuticals AUD 33.24M 6.5M Jun/2025